XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock award plan - (Tables)
6 Months Ended
Jun. 30, 2024
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2023

 

9,600,399

$

43.59

 

  

 

  

Granted

 

864,855

$

25.70

 

  

 

  

Exercised

 

(192,210)

$

22.10

 

  

 

  

Forfeited/Cancelled

 

(991,305)

$

45.80

 

  

 

  

Outstanding at June 30, 2024

 

9,281,739

$

42.13

 

5.77

years

$

14,161

Vested or Expected to vest at June 30, 2024

 

1,904,403

$

37.27

 

8.54

years

$

4,115

Exercisable at June 30, 2024

 

7,177,321

$

43.68

 

4.94

years

$

9,453

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Six months ended

    

    

June 30, 2024

    

Risk-free interest rate

 

4.23% - 4.66%

 

Expected volatility

 

53% - 54%

 

Expected term

 

5.5 years

 

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2023

2,866,270

$

41.82

Granted

 

1,800,930

25.72

Vested

 

(891,879)

44.35

Forfeited

 

(172,476)

37.61

Unvested at June 30, 2024

 

3,602,845

$

33.35

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2024

    

2023

    

2024

    

2023

Research and development

$

9,428

$

15,529

$

18,395

$

30,842

Selling, general and administrative

 

9,815

 

13,842

 

19,226

 

27,344

Total

$

19,243

$

29,371

$

37,621

$

58,186